CD274 and neoplasm: It could be speculated that in the absence of the MSI-high phenomenon, the response to ICI therapy might reflect the modulation of PD-1 expression on T cells of the tumor microenvironment and PDL-1 on the tumor cells themselves, as well as the high mutational load of the tumor.